FDA Investigator Mathew T Thomas, MD
Mathew T Thomas, MD has inspections in 7 countries as of 21 Jan 2022. Mathew T Thomas, MD has collaborated with a combined 579 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
21 Jan 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
India,
United States of America,
Peru,
Guatemala,
Czechia,
Costa Rica
Co-Investigator(s):
Adetutu M Gidado,
Barbara D Wright,
Barbara M Frazier,
Bei Yu,
Betsy C Galliher,
Byungja E Marciante,
Camille D Brown,
CDR Rochelle B Young, RPh, MSA,
Christine H Kujawski,
Damon C Green, MD,MS,
Dana M Daigle,
Daniel J Roberts,
Debra L Boyd Seale,
Diane Cvan Leeuwen,
Eileen J Bannerman,
Felix Maldonado,
Gene R Gunn,
Gregson A Joseph,
Gwyn G Dickinson,
Jeffrey M Watson,
Katherine Szestypalow,
Kenneth R Merritt,
Laree A Tracy,
Randall N Johnson,
Scott T Ballard,
Shirley S Wen,
Susan D Yuscius,
Thea C Grome,
Vanessa E Coulter,
William P Tonkins,
Yvonne E Lozano,
Yvonne Lozano
Mathew T Thomas, MD's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2000 | FDA 483 | Dr. C. Andrew DeAbate, M.D., Clinical Investigator - Form 483, 2000-06-27 |
August, 2000 | FDA 483 | Adib F. Rodriguez Solares, M.D. - Form 483, 2000-08-04 |
February, 2005 | FDA 483 | Dr. Marco A. Camere - Form 483, 2005-02-11 |
January, 2019 | FDA 483 | Madhukar H. Trivedi, MD - Form 483, 2019-01-11 |
May, 2002 | EIR | Dunlap, Frank E Dr - EIR, 2002-05-09 |
January, 2019 | EIR | IQVIA - EIR, 2019-01-30 |
August, 2000 | EIR | Adib F. Rodriguez Solares, M.D. - EIR, 2000-08-02 |
March, 2017 | FDA 483 | Unichem Laboratories Limited - Form 483, 2017-03-20 |
February, 2019 | EIR | Janssen Research & Development, LLC - EIR, 2019-02-04 |
August, 2000 | FDA 483 Response | Adib F. Rodriguez Solares, M.D. - Form 483R, 2000-08-28 |
February, 2005 | EIR | Dr. Marco A. Camere - EIR, 2005-02-11 |
June, 2000 | FDA 483 | Westbank Research Centers, Inc. - Form 483, 2000-06-27 |
November, 2001 | FDA 483 | C/O ICIC LATIN AMERICA - Form 483, 2001-11-02 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more